HTGM News and Press, HTG Molecular Diagnostics Inc. From 05/12/22

HTG Molecular Diagnostics, Inc. (HTGM) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, CFO, Secretary & Treasurer Conference Call Participants Dipesh Patel - ...

HTG Molecular press release (NASDAQ:HTGM): Q1 GAAP EPS of -$0.81. Revenue of $1.18M. For further details see: HTG Molecular GAAP EPS of -$0.81, revenue of $1.18M

TUCSON, Ariz., May 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business highlights and financial results for ...

AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...

HTG Molecular (NASDAQ:HTGM) is scheduled to announce Q1 earnings results on Thursday, May 12th, after market close. The consensus EPS Estimate is -$0.71 and the consensus Revenue Estimate is $2.15M (+49.3% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward...

TUCSON, Ariz., May 05, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter...

Gainers: AlloVir (ALVR) +41%. Biophytis (BPTS) +22%. Clarus Therapeutics (CRXT) +22%. Healthcare Services (HCSG) +20%. BioSig Technologies (BSGM) +6%. Losers: Arcturus Therapeutics (ARCT) -22%. Diffusion Pharmaceuticals (DFFN) -13%. Seer (SEER) -7%. HTG Molecular...

HTG Molecular Diagnostics (HTGM +18.8%) has announced that it has improved the sample preparation protocol for its miRNA Whole Transcriptome Assay so that it is now harmonized with the HTG Transcriptome Panel. The harmonized protocol is designed to enable customers to process a sing...

Buying Penny Stocks Today? What to Know as the Fed Changes Rates With big news coming from the Fed yesterday, how will penny stocks be affected? Well, with any major news update, those who invest in penny stocks need to understand exactly what will go on in the stock market. Because...

Momentus MNTS +40% on signing launch service agreements with SpaceX. HTG Molecular Diagnostics (HTGM) +32% expands features of proprietary HTG EdgeSeq technology. ERYTECH Pharma ERYP +19% British Journal of Haematology publishes positive results from Erytech's phase 2...